The Hartford
HIG
$136.10
-0.74%
The Hartford Insurance Group, Inc. is a diversified insurance and financial services company providing property and casualty insurance, group benefits, and mutual funds through its five reportable segments: Business Insurance, Personal Insurance, Property & Casualty Other Operations, Employee Benefits, and Hartford Funds. As a well-established player in the U.S. insurance market, The Hartford is recognized for its service excellence and strong brand trust, competing alongside major carriers like Travelers and Chubb. The current investor narrative centers on the company's consistent earnings growth, robust capital returns through dividends and buybacks, and its ability to navigate a competitive pricing environment while maintaining underwriting discipline. Recent analyst actions, including a downgrade by Piper Sandler in July 2026, highlight ongoing debate about the sustainability of premium growth and margin expansion in a softening market.…
HIG
The Hartford
$136.10
Investment Opinion: Should I buy HIG Today?
Rating: Buy. The Hartford offers a compelling value proposition with a forward PE of 9.94x, a PEG of 0.36, and a dividend yield of 1.58%, supported by strong earnings growth of 35.9% YoY in Q1 2026. The analyst consensus is 'Buy' with an average target of $149.85, implying ~10.1% upside, and the low beta of 0.458 provides defensive characteristics. The company's revenue growth of 6.11% YoY and operating margin expansion to 14.63% from 11.50% in Q1 2025 indicate improving profitability, while free cash flow of $5.82B TTM supports capital returns. However, the recent margin decline and analyst downgrade warrant caution, and the stock's underperformance relative to the S&P 500 suggests market skepticism. This Buy rating would be upgraded if the stock pulls back to below $130, offering a higher margin of safety, or downgraded to Hold if revenue growth decelerates below 4% or gross margins fall below 40%. Overall, HIG appears undervalued relative to its growth prospects and historical valuation, making it an attractive addition for value-oriented investors.
Sign up to view all
HIG 12-Month Price Forecast
The AI assessment leans bullish due to the compelling valuation and strong earnings momentum, but confidence is medium given the margin pressure and recent analyst downgrade. The stock's low beta and solid capital returns make it a defensive pick, but the market's relative weakness suggests caution. If the company can sustain revenue growth above 5% and stabilize margins, the stock is likely to re-rate higher. However, any signs of deteriorating underwriting performance would prompt a downgrade to neutral.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on The Hartford's 12-month outlook, with a consensus price target around $149.85 and implied upside of +10.1% versus the current price.
Average Target
$149.85
0 analysts
Implied Upside
+10.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$135 - $164
Analyst target range
The target price range of $135.00 to $164.00 shows a spread of $29.00, or 21.5% of the average target, indicating moderate uncertainty about the stock's future performance. The high target of $164.00 likely assumes continued strong underwriting results, favorable reserve development, and potential multiple expansion, while the low target of $135.00 may factor in softer pricing, higher catastrophe losses, or a broader market downturn. Recent institutional ratings show a mix of actions: Piper Sandler downgraded from Overweight to Neutral in July 2026, while Wells Fargo, Mizuho, and Cantor Fitzgerald maintained or reiterated positive ratings, suggesting that while some analysts are cautious, the overall sentiment remains constructive. The wide range reflects the inherent uncertainty in insurance earnings due to catastrophe exposure and investment market volatility.
Bulls vs Bears: HIG Investment Factors
The Hartford presents a mixed picture: strong earnings growth and attractive valuation are offset by margin pressure and relative market weakness. The bull case is supported by a low PEG ratio, solid capital returns, and a defensive beta, while the bear case highlights revenue growth that lags the market, a recent downgrade, and declining gross margins. Currently, the evidence slightly favors the bulls due to the compelling valuation and earnings momentum, but the key tension lies in whether the company can sustain its underwriting margins and revenue growth in a competitive environment. If margins stabilize and growth continues, the stock could re-rate higher; if not, it may continue to underperform.
Bullish
- Strong Earnings Growth: Q1 2026 net income surged 35.9% YoY to $856M from $630M, driven by improved underwriting and investment income. This demonstrates strong operational execution and earnings power.
- Attractive Valuation with PEG of 0.36: The stock trades at a forward PE of 9.94x and a PEG of 0.36, well below the industry average PE of ~15x. This suggests the market is pricing in limited growth, offering a margin of safety for value investors.
- Solid Capital Returns: The company has a dividend yield of 1.58% and a low payout ratio of 16%, indicating ample room for dividend increases and buybacks. This supports shareholder returns and signals financial strength.
- Low Beta and Defensive Appeal: With a beta of 0.458, HIG offers stability in turbulent markets, making it an attractive defensive holding. Its 1-year price change of +2.18% lags the S&P 500 but provides downside protection.
Bearish
- Revenue Growth Lags Market: While revenue grew 6.11% YoY in Q1 2026, the stock's 1-year return of +2.18% significantly underperformed the S&P 500's +20.48%. This relative weakness suggests the market is not rewarding the company's growth.
- Margin Pressure in Q1: Gross margin declined to 44.67% in Q1 2026 from 48.95% in Q4 2025, indicating rising costs or competitive pricing pressures. This could signal deteriorating underwriting profitability.
- Recent Analyst Downgrade: Piper Sandler downgraded HIG from Overweight to Neutral in July 2026, reflecting concerns about premium growth sustainability and margin expansion in a softening market. This negative sentiment could weigh on the stock.
- High Target Price Spread: The analyst target range of $135 to $164 shows a 21.5% spread from the average, indicating significant uncertainty about future performance. This wide dispersion suggests divergent views on the company's outlook.
HIG Technical Analysis
The Hartford's stock has been in a broad uptrend over the past year, with a 1-year price change of +2.18%, though this significantly lags the S&P 500's +20.48% gain, indicating relative weakness. The current price of $136.10 sits at 73.5% of the 52-week range (between $120.33 low and $146.07 high), suggesting the stock is in the upper-middle portion of its range, reflecting a recovery from the June lows but still below the July peak. The 52-week high of $146.07 was reached on July 29, 2026, and the stock has since pulled back, indicating potential resistance near that level.
Beta
0.46
0.46x market volatility
Max Drawdown
-12.3%
Largest decline past year
52-Week Range
$120-$146
Price range past year
Annual Return
+2.2%
Cumulative gain past year
| Period | HIG Return | S&P 500 |
|---|---|---|
| 1m | -3.4% | +3.6% |
| 3m | +0.1% | +2.7% |
| 6m | -4.3% | +11.4% |
| 1y | +2.2% | +18.7% |
| ytd | -0.7% | +12.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HIG Fundamental Analysis
The Hartford's revenue has shown steady growth, with Q1 2026 revenue of $7.226 billion, up 6.11% year-over-year from $6.81 billion in Q1 2025. This growth is consistent with the prior quarters: Q4 2025 revenue was $7.312 billion, Q3 2025 was $7.232 billion, and Q2 2025 was $6.987 billion, reflecting a stable upward trajectory. The company's net income has also grown, with Q1 2026 net income of $856 million, up from $630 million in Q1 2025, a 35.9% increase, driven by improved underwriting and investment income. However, the gross margin in Q1 2026 was 44.67%, down from 48.95% in Q4 2025, indicating some margin pressure, though the operating margin improved to 14.63% from 11.50% in Q1 2025.
Quarterly Revenue
$7.2B
2026-03
Revenue YoY Growth
+6.1%
YoY Comparison
Gross Margin
44.7%
Latest Quarter
Free Cash Flow
$5.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HIG Overvalued?
Given that The Hartford has positive net income, the primary valuation metric selected is the price-to-earnings (PE) ratio. The trailing PE is 10.20x, while the forward PE is 9.94x, indicating that the market expects modest earnings growth, with the forward multiple slightly lower. The stock's PEG ratio of 0.36 suggests that the stock is undervalued relative to its expected earnings growth, which is attractive for value investors. Compared to the industry average PE of approximately 15x (based on typical insurance sector multiples), The Hartford trades at a 32% discount, which may reflect its lower growth prospects or market skepticism about its ability to sustain underwriting margins.
PE
10.2x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 6x~15x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
8.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The Hartford's debt-to-equity ratio is 0.23, indicating moderate leverage, but its interest expense of $50M per quarter is manageable given operating income of $1.057B in Q1 2026. However, the gross margin declined from 48.95% in Q4 2025 to 44.67% in Q1 2026, suggesting potential cost pressures that could erode profitability if sustained. The company's reliance on investment income, which can be volatile, adds another layer of financial risk, as seen in the net income swing from $630M in Q1 2025 to $856M in Q1 2026, driven partly by market conditions. Cash flow generation remains strong with FCF of $5.82B TTM, but any significant catastrophe losses could strain capital.
FAQ
The key risks include: 1) Financial risk from margin compression, as seen in the Q1 2026 gross margin decline to 44.67% from 48.95% in Q4 2025, which could reduce profitability. 2) Market risk from the stock's underperformance relative to the S&P 500, with a 1-year return of +2.18% vs +20.48%, indicating potential continued weakness. 3) Competitive risk from pricing pressure in the insurance industry, highlighted by the Piper Sandler downgrade. 4) Macro risk from catastrophe losses or investment market volatility, which could impact earnings. The most severe risk is a combination of these factors leading to a drop to the 52-week low of $120.33, a -11.6% decline.
The 12-month forecast for HIG is moderately bullish, with a base case target of $140-$150 (50% probability) and a bull case target of $150-$164 (30% probability), while the bear case is $120-$135 (20% probability). The most likely scenario is the base case, where the stock reaches the analyst average target of $149.85, implying a 10.1% gain. This assumes steady revenue growth and stable margins. The bull case would require stronger-than-expected earnings and multiple expansion, while the bear case would be triggered by margin deterioration or major losses. Overall, the risk-reward is skewed to the upside given the low valuation.
HIG appears undervalued based on its forward PE of 9.94x, which is 32% below the industry average of ~15x. The PEG ratio of 0.36 further suggests that the market is not fully pricing in the company's earnings growth potential. Compared to its own history, the stock trades near the lower end of its PE range, indicating a potential value opportunity. The market seems to be pricing in modest growth and possible margin erosion, but if the company delivers on its earnings estimates, the stock could re-rate higher. Overall, the valuation is attractive, but the discount may reflect legitimate concerns about the competitive environment.
HIG is a good buy for value investors seeking a defensive stock with a low PE of 9.94x and a PEG of 0.36, indicating undervaluation relative to growth. The analyst consensus is 'Buy' with an average target of $149.85, implying ~10.1% upside. However, the stock has underperformed the market, and margin pressure could limit near-term gains. It is best suited for long-term investors who can tolerate short-term volatility and are attracted to the 1.58% dividend yield. If you are looking for growth, other stocks may be more suitable, but for income and stability, HIG is a solid choice.
HIG is more suitable for long-term investment due to its low beta of 0.458, which provides stability, and its dividend yield of 1.58%, which rewards patient investors. The stock's earnings growth and capital returns make it a good candidate for a buy-and-hold strategy over a 3-5 year period. Short-term trading is possible, but the stock's low volatility and relative weakness may limit quick gains. Given the current valuation, a minimum holding period of 2-3 years is recommended to allow the market to recognize the company's value. For income-focused investors, HIG can be a core holding, while growth investors may find better opportunities elsewhere.